annual accounts payable:
$1.34M+$810.00K(+152.26%)Summary
- As of today (August 22, 2025), ELVN annual accounts payable is $1.34 million, with the most recent change of +$810.00 thousand (+152.26%) on December 31, 2024.
- During the last 3 years, ELVN annual accounts payable has fallen by -$1.18 million (-46.77%).
- ELVN annual accounts payable is now -46.77% below its all-time high of $2.52 million, reached on December 31, 2021.
Performance
ELVN Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$2.35M+$789.00K(+50.51%)Summary
- As of today (August 22, 2025), ELVN quarterly accounts payable is $2.35 million, with the most recent change of +$789.00 thousand (+50.51%) on June 30, 2025.
- Over the past year, ELVN quarterly accounts payable has increased by +$1.27 million (+117.08%).
- ELVN quarterly accounts payable is now -59.88% below its all-time high of $5.86 million, reached on March 31, 2023.
Performance
ELVN quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ELVN Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +152.3% | +117.1% |
| 3 y3 years | -46.8% | +107.1% |
| 5 y5 years | -19.1% | +40.9% |
ELVN Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | +800.7% | -59.9% | +1477.8% |
| 5 y | 5-year | -46.8% | +800.7% | -59.9% | +1477.8% |
| alltime | all time | -46.8% | +800.7% | -59.9% | +1477.8% |
ELVN Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.35M(+50.5%) |
| Mar 2025 | - | $1.56M(+16.4%) |
| Dec 2024 | $1.34M(+152.3%) | $1.34M(+31.7%) |
| Sep 2024 | - | $1.02M(-5.9%) |
| Jun 2024 | - | $1.08M(-60.3%) |
| Mar 2024 | - | $2.73M(+412.6%) |
| Dec 2023 | $532.00K(+257.0%) | $532.00K(-64.4%) |
| Sep 2023 | - | $1.49M(-47.5%) |
| Jun 2023 | - | $2.84M(-51.5%) |
| Mar 2023 | - | $5.86M(+3832.9%) |
| Dec 2022 | $149.00K | $149.00K(-80.6%) |
| Sep 2022 | - | $767.00K(-32.4%) |
| Jun 2022 | - | $1.14M(-39.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.88M(-20.2%) |
| Dec 2021 | $2.52M(+27.9%) | - |
| Dec 2021 | - | $2.36M(-4.7%) |
| Sep 2021 | - | $2.48M(-5.7%) |
| Jun 2021 | - | $2.63M(-12.5%) |
| Mar 2021 | - | $3.00M(+52.3%) |
| Dec 2020 | $1.97M(+18.9%) | $1.97M(+4.5%) |
| Sep 2020 | - | $1.89M(+13.0%) |
| Jun 2020 | - | $1.67M(-28.1%) |
| Mar 2020 | - | $2.32M |
| Dec 2019 | $1.66M(+82.6%) | - |
| Dec 2018 | $908.00K(+110.7%) | - |
| Dec 2017 | $431.00K | - |
FAQ
- What is Enliven Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Enliven Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of ELVN is $1.34M
What is the all time high annual accounts payable for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual accounts payable is $2.52M
What is Enliven Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, ELVN annual accounts payable has changed by +$810.00K (+152.26%)
What is Enliven Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of ELVN is $2.35M
What is the all time high quarterly accounts payable for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly accounts payable is $5.86M
What is Enliven Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, ELVN quarterly accounts payable has changed by +$1.27M (+117.08%)